Hyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healing

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéuticagl
dc.contributor.authorAmato, Giovanni
dc.contributor.authorGrimaudo, Maria Aurora
dc.contributor.authorÁlvarez Lorenzo, Carmen
dc.contributor.authorConcheiro Nine, Ángel Joaquín
dc.contributor.authorCarbone, Claudia
dc.contributor.authorBonaccorso, Angela
dc.contributor.authorPuglisi, Giovanni
dc.contributor.authorMusumeci, Teresa
dc.date.accessioned2021-01-15T08:02:04Z
dc.date.available2021-01-15T08:02:04Z
dc.date.issued2021
dc.description.abstractPhysiological wound healing process can be delayed in the presence of certain pathologies, such as diabetes or cancer. In this perspective, the aim of this study was to design a new nanogel platform of hyaluronan, poly-L-lysine and berberine suitable for wound treatment. Two different nanogel formulations were selected after a first formulation screening. They were prepared by adding dropwise 2 mg/mL hyaluronan aqueous solution (200 or 700 kDa) to 1.25 mg/mL poly-L-lysine aqueous solution. Blank nanogels formulated with 200 kDa HA resulted stable after freeze-drying with dimensions, polydispersity index and zeta potential of 263.6 ± 13.1 nm, 0.323 ± 0.029 and 32.7 ± 3.5 mV, respectively. Both blank and berberine-loaded nanogels showed rounded-shape structures. Loaded nanogels released nearly 50% of loaded berberine within 45 min, whereas the remaining 50% was released up to 24 h in vitro. Both, blank and berberine-loaded nanogels were able to completely close the fibroblasts gap in 42 hgl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was supported by a grant from the Italian Ministry of Research [Grant PRIN 2017 #20173ZECCM Tracking biological barriers to antigen delivery by nanotechnological vaccines (NanoTechVax)], by Research Funding for the University of Catania [Piano per la Ricerca 2016–2018–Linea di intervento 2 “Dotazione Ordinaria], by MINECO Spain [SAF2017-83118-R], FEDER and Xunta de Galicia Spain [ED431C 2020/17]gl
dc.identifier.citationAmato, G.; Grimaudo, M.A.; Alvarez-Lorenzo, C.; Concheiro, A.; Carbone, C.; Bonaccorso, A.; Puglisi, G.; Musumeci, T. Hyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healing. Pharmaceutics 2021, 13, 34gl
dc.identifier.doi10.3390/pharmaceutics13010034
dc.identifier.essn1999-4923
dc.identifier.urihttp://hdl.handle.net/10347/24191
dc.language.isoenggl
dc.publisherMDPIgl
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/SAF2017-83118-R/ES/ARQUITECTURAS POLIMERICAS 3D ACTIVAS PARA MEDICINA REGENERATIVA Y TERAPIA LOCALIZADA
dc.relation.publisherversionhttps://doi.org/10.3390/pharmaceutics13010034gl
dc.rights© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)gl
dc.rightsAtribución 4.0 Internacional
dc.rights.accessRightsopen accessgl
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHyaluronangl
dc.subjectε-polylysinegl
dc.subjectBerberinegl
dc.subjectChronic woundsgl
dc.subjectNanogelsgl
dc.titleHyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healinggl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication44d6632e-65cd-485a-bb67-86df5567793a
relation.isAuthorOfPublicationfbd9d3a4-b1f4-4aff-8472-de22b1c140c4
relation.isAuthorOfPublication.latestForDiscoveryfbd9d3a4-b1f4-4aff-8472-de22b1c140c4

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021_pharmaceutics_amato_hyaluronan.pdf
Size:
2.01 MB
Format:
Adobe Portable Document Format
Description: